In the summary consolidated statements of cash flows and throughout this release, the company refers to free cash flow. The table below presents a reconciliation of this non-GAAP financial measure to net cash used in operating activities, the most directly comparable GAAP financial measure.
For the Three Months Ended September 30, |
For the Nine Months Ended September 30, |
|||||||||||||||||||
2012 | 2011 | 2012 | 2011 | |||||||||||||||||
Net cash provided by (used in) operating activities | $ | 341,752 | $ | (1,303 | ) | $ | 300,422 | $ | (32,560 | ) | ||||||||||
Purchases of property, equipment, & technology licenses | (949 | ) | (697 | ) | (1,979 | ) | (2,523 | ) | ||||||||||||
Patent additions | (4,918 | ) | (6,302 | ) | (19,783 | ) | (19,428 | ) | ||||||||||||
Free cash flow | $ | 335,885 | $ | (8,302 | ) | $ | 278,660 | $ | (54,511 | ) | ||||||||||